References
- Allain J P., Verroust F, Soulier J P. In vitro and in vivo characterization of factor VIII preparations. Vox Sang 1980; 38: 68
- Griffith G C., Nichols G, Jr, Asher J D., Flanagan B. Heparin osteoporosis. JAMA 1965; 193: 85
- Hellgren M. Thromboembolism and Pregnancy. Stockholm, Sweden 1981, (thesis)
- Hellgren M, Tengborn L, Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest 1982; 14: 127
- McKay E J. A simple two-step procedure for the isolation of antithrombin III from biological fluids. Thromb Res 1981; 21: 375
- Miller-Andersson M, Borg H, Andersson L-O. Purification of antithrombin III by affinity chromatography. Thromb Res 1974; 5: 439
- Ødegård O R., Lie M, Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res 1975; 6: 287
- Tengborn L, Frohm B, Johansson L, Nilsson L-E. Heat treated antithrombin III concentrate. Studies of in vitro and in vivo properties. Vox Sang 1984, (in press)
- Wise P H., Hall A J. Heparin-induced osteopenia in pregnancy. Br Med J 1980; 281: 110